| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |